K2M commenced full launch of the next-generation YUKON OCT posterior fixation system, designed to support cervical sagittal balance in the occipito-cervico-thoracic regions.
Cerapedics received FDA approval for an IDE clinical trial of P-15L Peptide Enhanced Bone Graft vs. autograft in TLIF to treat degenerative disc disease.